[
    [
        {
            "time": "",
            "original_text": "公告精选：梅雁吉祥被举牌遭闪电问询；凯恩股份控股股东所质押部份股票触及平仓线",
            "features": {
                "keywords": [
                    "梅雁吉祥",
                    "举牌",
                    "闪电问询",
                    "凯恩股份",
                    "控股股东",
                    "质押",
                    "平仓线"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "股票市场"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "公告精选：梅雁吉祥被举牌遭闪电问询；凯恩股份控股股东所质押部份股票触及平仓线",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "上海莱士：拟约160亿并购控股股东资产 明起停牌",
            "features": {
                "keywords": [
                    "上海莱士",
                    "并购",
                    "控股股东",
                    "资产",
                    "停牌"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海莱士：拟约160亿并购控股股东资产 明起停牌",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "上海莱士：拟超160亿元收购天诚国际投资及子公司",
            "features": {
                "keywords": [
                    "上海莱士",
                    "收购",
                    "天诚国际投资",
                    "子公司"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "海外投资"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海莱士：拟超160亿元收购天诚国际投资及子公司",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "上海莱士：拟收购控股股东旗下资产，交易作价或超160亿元",
            "features": {
                "keywords": [
                    "上海莱士",
                    "收购",
                    "控股股东",
                    "资产",
                    "交易作价"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "资本市场"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "上海莱士：拟收购控股股东旗下资产，交易作价或超160亿元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药圈五大投融资并购事件 将彻底改变行业格局!",
            "features": {
                "keywords": [
                    "医药圈",
                    "投融资",
                    "并购",
                    "行业格局"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "行业整合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药圈五大投融资并购事件 将彻底改变行业格局!",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]